通过向PI3K/Akt/mTOR通路,对乳腺癌和卵巢癌产生 Melatonin 的作用
Vahid Pourbarkhordar1,2, Sohrab Rahmani1,2, Ali Roohbakhsh2,3
1Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
IUBMB life
|August 30, 2024
概括
黑素通过抑制PI3K/Akt/mTOR通路在乳腺癌和卵巢癌中表现出抗癌作用. 它降低关键蛋白质的调节,诱导亡,并促进自,提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 腺激素 - - 氨酸,是一种腺激素,表现出抗癌性质.
- 过度激活PI3K/Akt/mTOR通路在乳腺癌和卵巢癌等固体瘤中很常见.
- 目前的癌症疗法面临着包括毒性和耐药性在内的局限性,需要新的治疗点.
研究的目的:
- 审查黑激素对乳腺和卵巢癌的影响.
- 专注于黑激素在调节PI3K/Akt/mTOR信号通路中的作用.
- 探索黑激素作为向癌症治疗的潜力.
主要方法:
- 对调查黑激素对癌症影响的研究的文献综述.
- 对黑素影响PI3K/Akt/mTOR通路的分子机制的分析.
- 检查黑激素对亡和自途径的影响.
主要成果:
- 黑色素降低PI3K/Akt/mTOR通路的关键组成部分,包括PTEN,PI3K,Akt和mTOR.
- 黑色素通过影响MDM2,Bad,Bcl-XL和p53.3来诱导亡.
- 黑色素通过ULK1和Beclin-1激活促进自,影响PI3K复合体I的活性.
结论:
- 黑色素有效地抑制PI3K/Akt/mTOR途径在乳腺和卵巢癌.
- 黑素的多方面的机制,包括亡和自诱导,呈现出一个有希望的治疗途径.
- 了解黑激素与AMPK和Wnt/β-catenin等重叠途径的相互作用,可以提高癌症治疗策略.
更多相关视频
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Management of Insomnia
235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K


